Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

Systematic discovery of natural CRISPR-Cas12a inhibitors

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins

Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

Diverse mechanisms of CRISPR-Cas9 inhibition by type II anti-CRISPR proteins

A Broad-Spectrum Inhibitor of CRISPR-Cas9

Disabling Cas9 by an anti-CRISPR DNA mimic

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

De novo design of potent CRISPR-Cas13 inhibitors

Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes

Structural Basis for AcrVA4 Inhibition of Specific CRISPR-Cas12a

Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Temperature-Responsive Competitive Inhibition of CRISPR-Cas9

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

The discovery and development of Cas12A